WallStreetZenWallStreetZen

NASDAQ: SLXN
Silexion Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Silexion Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SLXN annual revenue was $0.0, with N/A growth year-over-year.

SLXN revenue history

Current Revenue
$0.0
Current Earnings
$7.5M
Current Profit Margin
0%

Be the first to know when SLXN announces revenue.

SLXN Revenue History By Year

SLXN Yearly RevenueSLXN RevenueSLXN ChangeSLXN Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A

1 of 1

Silexion Therapeutics Revenue FAQ

What was SLXN's revenue last quarter?

On Invalid Date, Silexion Therapeutics (NASDAQ: SLXN) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Silexion Therapeutics's revenue was $0.00.

What was Silexion Therapeutics's revenue in 2023?

Silexion Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Silexion Therapeutics make in a day?

Based on Silexion Therapeutics annual revenue for the past two years, SLXN makes an average of $0.00 per day.

What was Silexion Therapeutics's annual revenue growth in the past year?

As of Q1 2025, Silexion Therapeutics's revenue has grown null year over year. Silexion Therapeutics's revenue in the past year totaled $0.00.

How much does Silexion Therapeutics make in a year?

Silexion Therapeutics's revenue by year for the past two years is:
  • Silexion Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Silexion Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.